EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Magnetocardiography for Exploratory Risk Stratification in Patients With Three‐Vessel Coronary Artery Disease: A Single‐Center Prospective Cohort Study

Ziyu An iD, Shipan Wang, Min Zhang, Mingduo Zhang, Lanxin Feng iD, Shuwen Yang, Qi Zhou iD, Haiyang Hu, Chenchen Tu iD, Hongjia Zhang iD, Xiantao Song iD

Cardiovascular Therapeutics · 2026-01 · 2026 (1)

DOI: 10.1155/cdr/5552371 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Cardiovascular Therapeutics, online erschienen am 16.07.2026. Verfasst von Ziyu An und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China, ccmu.edu.cn. Hauptthemen laut MEDLINE: Magnetocardiography, Coronary Artery Disease. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Hospitals Authority's Ascent Plan, Beijing Municipal Health Commission, Project of the Beijing Lab for Cardiovascular Precision Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Patients with three‐vessel coronary artery disease (3V‐CAD) remain at heterogeneous risk for major adverse cardiovascular and cerebrovascular events (MACCE) after revascularization. Magnetocardiography (MCG) is a noncontact and radiation‐free technique that may capture electrophysiological abnormalities not reflected by anatomical risk scores. This study evaluated the exploratory prognostic value of MCG‐derived parameters in patients with 3V‐CAD.

Methods

This single‐center prospective cohort study included 544 patients with 3V‐CAD who underwent coronary revascularization. MCG recordings were obtained before revascularization using a 36‐channel optically pumped magnetometer‐based system. The primary endpoint was MACCE, defined as cardiac death, stroke, myocardial infarction, or unplanned revascularization. Cox regression models were constructed using clinical variables, SYNTAX score, and an MCG composite variable. Model performance was assessed using discrimination, calibration, decision curve analysis, and bootstrap internal validation.

Results

During a median follow‐up of 725 days, 37 patients (6.8%) experienced MACCE. The SYNTAX score was independently associated with MACCE after adjustment for clinical variables and MCG score (hazard ratio [HR], 1.08; 95% confidence interval [CI], 1.04–1.12; p < 0.001). The MCG composite variable was also associated with MACCE after adjustment for clinical variables and SYNTAX score (HR, 2.74; 95% CI, 1.57–4.79; p < 0.001). Model discrimination increased from 0.596 for clinical variables alone to 0.682 after adding SYNTAX score and to 0.727 after adding MCG. However, the improvement from the clinical + SYNTAX model to the MCG‐added model was not statistically significant ( p = 0.17). Bootstrap validation showed an optimism‐corrected C ‐index of 0.672.

Conclusion

MCG‐derived parameters were associated with MACCE and may provide complementary electrophysiological information for exploratory risk stratification in patients with 3V‐CAD after revascularization. Larger multicenter studies with external validation are needed to confirm its complementary prognostic value. Trial Registration Chinese Clinical Trial Registry identifier: ChiCTR2200066942

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MagnetocardiographyCoronary Artery DiseaseHumansProspective StudiesFemaleMalePredictive Value of TestsAgedMiddle AgedRisk AssessmentRisk FactorsTime FactorsTreatment OutcomePercutaneous Coronary InterventionStroke

Stichwörter der Autor:innen

SYNTAX scorecoronary artery diseasemagnetocardiographyprognosticthree-vessel coronary artery disease

Autor:innen und Institutionen

  • Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China, ccmu.edu.cn.
  • Department of Cardiovascular Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, China, ccmu.edu.cn.
  • Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung, Blood Vessel Diseases, Beijing, China, heartinsti.com.
  • Department of Cardiology, Beijing Friendship Hospital, Capital Medical University, Beijing, China, ccmu.edu.cn.

ORCID-Profile: Ziyu An, Lanxin Feng, Qi Zhou, Chenchen Tu, Hongjia Zhang, Xiantao Song

Förderung

  • Beijing Hospitals Authority's Ascent Plan
  • Beijing Municipal Health Commission
  • Project of the Beijing Lab for Cardiovascular Precision Medicine
  • Beijing Nova Program
  • Coordinated Innovation of Scientific and Technological in the Beijing-Tianjin-Hebei Region
  • Capital's Funds for Health Improvement and Research

Zitieren

APA

An, Z., Wang, S., Zhang, M., Zhang, M., Feng, L., Yang, S., Zhou, Q., Hu, H., Tu, C., Zhang, H., & Song, X. (2026). Magnetocardiography for Exploratory Risk Stratification in Patients With Three‐Vessel Coronary Artery Disease: A Single‐Center Prospective Cohort Study. Cardiovascular Therapeutics, 2026(1). https://doi.org/10.1155/cdr/5552371

Vancouver

An Z, Wang S, Zhang M, Zhang M, Feng L, Yang S, et al. Magnetocardiography for Exploratory Risk Stratification in Patients With Three‐Vessel Coronary Artery Disease: A Single‐Center Prospective Cohort Study. Cardiovascular Therapeutics. 2026;2026(1). doi:10.1155/cdr/5552371

BibTeX
@article{An2026,
  author = {An, Ziyu and Wang, Shipan and Zhang, Min and Zhang, Mingduo and Feng, Lanxin and Yang, Shuwen and Zhou, Qi and Hu, Haiyang and Tu, Chenchen and Zhang, Hongjia and Song, Xiantao},
  title = {Magnetocardiography for Exploratory Risk Stratification in Patients With Three‐Vessel Coronary Artery Disease: A Single‐Center Prospective Cohort Study},
  journal = {Cardiovascular Therapeutics},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/cdr/5552371}
}
Kostenlos starten →